Key points from this week’s report:
Please refer to the attached PDF for the full report.
• The MSCI Asia ex. Japan index (AAXJ) pulled back from its 21-DMA resistance and is currently testing its 200-DMA. We
recommend a cautious and selective approach to increasing risk.
• Japan and Taiwan are in a Confirmed Uptrend. Five of 13 markets, including Hong Kong, China and Australia, are in an Uptrend
Under Pressure. Six markets, including India, are in a Rally Attempt.
• Japan was shifted to a Confirmed Uptrend from an Uptrend Under Pressure after the Nikkei closed at new highs for the year.
Year-to-date, the Nikkei index has outperformed the S&P 500 and the AAXJ despite a 4.6% increase in the USD to JPY exchange
rate. Over the last year, value has outperformed growth. Notably, the spread between the value and growth indexes has
remained mostly range bound between April 2022 and January 2023. However, the delta in value outperformance is now
increasing since January.
• We are noticing an improvement in breadth across Japanese sectors. The number of weekly stock breakouts has increased
significantly over the last few weeks, which is an encouraging sign. The Basic Material, Capital Equipment and Consumer
Cyclical sectors have led in Japan over the last four to eight weeks. Refer to page 11 for a list of stocks trading near pivot in
Japan.
• Highlighted Focus List Idea: Rohto Pharmaceutical (XP@N.JP; 4527 JP).